Your browser doesn't support javascript.
loading
Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer.
Daido, Wakako; Masuda, Takeshi; Imano, Nobuki; Matsumoto, Naoko; Hamai, Kosuke; Iwamoto, Yasuo; Takayama, Yusuke; Ueno, Sayaka; Sumii, Masahiko; Shoda, Hiroyasu; Ishikawa, Nobuhisa; Yamasaki, Masahiro; Nishimura, Yoshifumi; Kawase, Shigeo; Shiota, Naoki; Awaya, Yoshikazu; Suzuki, Tomoko; Kitaguchi, Soichi; Fujitaka, Kazunori; Nagata, Yasushi; Hattori, Noboru.
Afiliação
  • Daido W; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
  • Masuda T; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
  • Imano N; Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
  • Matsumoto N; Department of Respiratory Internal Medicine, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima 730-8619, Japan.
  • Hamai K; Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima 734-8530, Japan.
  • Iwamoto Y; Department of Medical Oncology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima 730-8518, Japan.
  • Takayama Y; Department of Respiratory Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima 730-8518, Japan.
  • Ueno S; Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima 734-8530, Japan.
  • Sumii M; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
  • Shoda H; Department of Respiratory Internal Medicine, Hiroshima City Hiroshima Citizens Hospital, Hiroshima 730-8518, Japan.
  • Ishikawa N; Department of Respiratory Medicine, Hiroshima Prefectural Hospital, Hiroshima 734-8530, Japan.
  • Yamasaki M; Department of Respiratory Internal Medicine, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima 730-8619, Japan.
  • Nishimura Y; Department of Respiratory Medicine, National Hospital Organization Higashihiroshima Medical Center, Hiroshima 739-0041, Japan.
  • Kawase S; Department of Respiratory Medicine, Kure Kyosai Hospital, Hiroshima 737-8505, Japan.
  • Shiota N; Department of Respiratory Disease, Chugoku Rousai General Hospital, Hiroshima 737-0193, Japan.
  • Awaya Y; Department of Respiratory Medicine, Miyoshi Central Hospital, Hiroshima 728-8502, Japan.
  • Suzuki T; Department of Respiratory Medicine, JA Onomichi General Hospital, Hiroshima 722-8508, Japan.
  • Kitaguchi S; Department of Respiratory Internal Medicine, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima 731-0232, Japan.
  • Fujitaka K; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
  • Nagata Y; Department of Radiation Oncology, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
  • Hattori N; Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Cancers (Basel) ; 14(24)2022 Dec 17.
Article em En | MEDLINE | ID: mdl-36551721
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça